Literature DB >> 30936095

Identification of a Novel Plasmid Carrying mcr-4.3 in an Acinetobacter baumannii Strain in China.

Furong Ma1, Cong Shen2,3, Yong Xia4, Guo-Bao Tian5,3, Xiaobin Zheng6, Yan Liu7, Hongtao Chen7, Lanlan Zhong2,3, Yingjian Liang6, Kang Liao8, Yongqiang Yang5,9.   

Abstract

Here, we identified mcr-4.3 in Acinetobacter baumannii, which had not been previously observed to carry an mcr gene. The mcr-4.3-harboring A. baumannii strain AB18PR065 was isolated from pig feces from a slaughterhouse in Guangdong Province of China. The mcr-4.3-carrying pAB18PR065 is 25,602 bp in size and could not be transferred in conjugation, transformation, and electroporation experiments, as we did not find any conjugation-related genes therein. pAB18PR065 harbors two copies of type II toxin-antitoxin systems, which are functional in plasmid stabilization and maintenance. pAB18PR065 shares similarity only with one recently identified plasmid, pAb-MCR4.3 (35,502 bp), from a clinical A. baumannii strain. It is likely that the emergence of pAb-MCR4.3 was due to the insertion of an 11,386-bp, ISAba19-based, composite transposon into pAB18PR065. These data indicate that mcr-4.3 was captured by an A. baumannii-original plasmid via horizontal gene transfer.
Copyright © 2019 American Society for Microbiology.

Entities:  

Keywords:  Acinetobacter baumanniizzm321990; colistin resistance; mcr-4.3zzm321990

Mesh:

Substances:

Year:  2019        PMID: 30936095      PMCID: PMC6535571          DOI: 10.1128/AAC.00133-19

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  36 in total

1.  Molecular characterization of carbapenemase and cephalosporinase genes among clinical isolates of Acinetobacter baumannii in a tertiary medical centre in Malaysia.

Authors:  Shirin Biglari; Hanafiah Alfizah; Ramli Ramliza; Md Mostafizur Rahman
Journal:  J Med Microbiol       Date:  2014-11-07       Impact factor: 2.472

2.  mcr-1 and mcr-2 variant genes identified in Moraxella species isolated from pigs in Great Britain from 2014 to 2015.

Authors:  Manal AbuOun; Emma J Stubberfield; Nick A Duggett; Miranda Kirchner; Luisa Dormer; Javier Nunez-Garcia; Luke P Randall; Fabrizio Lemma; Derrick W Crook; Christopher Teale; Richard P Smith; Muna F Anjum
Journal:  J Antimicrob Chemother       Date:  2017-10-01       Impact factor: 5.790

Review 3.  Porins, efflux pumps and multidrug resistance in Acinetobacter baumannii.

Authors:  Jordi Vila; Sara Martí; Javier Sánchez-Céspedes
Journal:  J Antimicrob Chemother       Date:  2007-02-26       Impact factor: 5.790

4.  Emergence of metallo-β-lactamase NDM-1-producing multidrug-resistant Escherichia coli in Australia.

Authors:  Laurent Poirel; Emilie Lagrutta; Peter Taylor; Jeanette Pham; Patrice Nordmann
Journal:  Antimicrob Agents Chemother       Date:  2010-09-07       Impact factor: 5.191

5.  Emergence of plasmid-mediated colistin resistance mechanism MCR-1 in animals and human beings in China: a microbiological and molecular biological study.

Authors:  Yi-Yun Liu; Yang Wang; Timothy R Walsh; Ling-Xian Yi; Rong Zhang; James Spencer; Yohei Doi; Guobao Tian; Baolei Dong; Xianhui Huang; Lin-Feng Yu; Danxia Gu; Hongwei Ren; Xiaojie Chen; Luchao Lv; Dandan He; Hongwei Zhou; Zisen Liang; Jian-Hua Liu; Jianzhong Shen
Journal:  Lancet Infect Dis       Date:  2015-11-19       Impact factor: 25.071

6.  Molecular characterization of extended-spectrum cephalosporinase-producing Salmonella enterica serovar Choleraesuis isolates from patients in Thailand and Denmark.

Authors:  Pantip Sirichote; Henrik Hasman; Chaiwat Pulsrikarn; Henrik Carl Schønheyder; Jurgita Samulioniené; Srirat Pornruangmong; Aroon Bangtrakulnonth; Frank M Aarestrup; Rene S Hendriksen
Journal:  J Clin Microbiol       Date:  2009-12-23       Impact factor: 5.948

7.  Diversity of bacterial type II toxin-antitoxin systems: a comprehensive search and functional analysis of novel families.

Authors:  Raphaël Leplae; Damien Geeraerts; Régis Hallez; Julien Guglielmini; Pierre Drèze; Laurence Van Melderen
Journal:  Nucleic Acids Res       Date:  2011-03-21       Impact factor: 16.971

8.  Novel Plasmid-Mediated Colistin Resistance Gene mcr-3 in Escherichia coli.

Authors:  Wenjuan Yin; Hui Li; Yingbo Shen; Zhihai Liu; Shaolin Wang; Zhangqi Shen; Rong Zhang; Timothy R Walsh; Jianzhong Shen; Yang Wang
Journal:  mBio       Date:  2017-06-27       Impact factor: 7.867

9.  A small Acinetobacter plasmid carrying the tet39 tetracycline resistance determinant.

Authors:  Mohammad Hamidian; Kathryn E Holt; Derek Pickard; Ruth M Hall
Journal:  J Antimicrob Chemother       Date:  2015-09-27       Impact factor: 5.790

10.  Action and mechanism of the colistin resistance enzyme MCR-4.

Authors:  Huimin Zhang; Mengyun Hou; Yongchang Xu; Swaminath Srinivas; Man Huang; Lizhang Liu; Youjun Feng
Journal:  Commun Biol       Date:  2019-01-25
View more
  12 in total

1.  A novel plasmid-encoded mcr-4.3 gene in a colistin-resistant Acinetobacter baumannii clinical strain.

Authors:  Natacha Martins-Sorenson; Erik Snesrud; Danilo Elias Xavier; Luciana Camila Cacci; Anthony T Iavarone; Patrick McGann; Lee W Riley; Beatriz Meurer Moreira
Journal:  J Antimicrob Chemother       Date:  2020-01-01       Impact factor: 5.790

Review 2.  Multidrug Resistant Acinetobacter baumannii: Resistance by Any Other Name Would Still be Hard to Treat.

Authors:  David A Butler; Mark Biagi; Xing Tan; Samah Qasmieh; Zackery P Bulman; Eric Wenzler
Journal:  Curr Infect Dis Rep       Date:  2019-11-16       Impact factor: 3.725

3.  Complete Nucleotide Sequences of mcr-4.3-Carrying Plasmids in Acinetobacter baumannii Sequence Type 345 of Human and Food Origin from the Czech Republic, the First Case in Europe.

Authors:  Ibrahim Bitar; Matej Medvecky; Tereza Gelbicova; Vladislav Jakubu; Jaroslav Hrabak; Helena Zemlickova; Renata Karpiskova; Monika Dolejska
Journal:  Antimicrob Agents Chemother       Date:  2019-09-23       Impact factor: 5.191

4.  Whole-Genome Sequencing of a Colistin-Resistant Acinetobacter baumannii Strain Isolated at a Tertiary Health Facility in Pretoria, South Africa.

Authors:  Noel-David Nogbou; Mbudzeni Ramashia; Granny Marumo Nkawane; Mushal Allam; Chikwelu Lawrence Obi; Andrew Munyalo Musyoki
Journal:  Antibiotics (Basel)       Date:  2022-04-28

Review 5.  Biological Control of Acinetobacter baumannii: In Vitro and In Vivo Activity, Limitations, and Combination Therapies.

Authors:  Benjamin Havenga; Brandon Reyneke; Monique Waso-Reyneke; Thando Ndlovu; Sehaam Khan; Wesaal Khan
Journal:  Microorganisms       Date:  2022-05-19

Review 6.  An overview of colistin resistance, mobilized colistin resistance genes dissemination, global responses, and the alternatives to colistin: A review.

Authors:  Mohammad H Gharaibeh; Shoroq Q Shatnawi
Journal:  Vet World       Date:  2019-11-08

7.  Analysis of Complete Genome Sequence of Acinetobacter baumannii Strain ATCC 19606 Reveals Novel Mobile Genetic Elements and Novel Prophage.

Authors:  Mohammad Hamidian; Lucia Blasco; Lauren N Tillman; Joyce To; María Tomas; Garry S A Myers
Journal:  Microorganisms       Date:  2020-11-24

8.  Ser253Leu substitution in PmrB contributes to colistin resistance in clinical Acinetobacter nosocomialis.

Authors:  Ya-Sung Yang; Wen-Yih Jeng; Yi-Tzu Lee; Chi-Ju Hsu; Yu-Ching Chou; Shu-Chen Kuo; Cheng-Cheung Chen; Wei-Jane Hsu; Hsing-Yu Chen; Jun-Ren Sun
Journal:  Emerg Microbes Infect       Date:  2021-12       Impact factor: 7.163

9.  Antimicrobial Resistance Mechanisms and Virulence of Colistin- and Carbapenem-Resistant Acinetobacter baumannii Isolated from a Teaching Hospital in Taiwan.

Authors:  Noor Andryan Ilsan; Yuarn-Jang Lee; Shu-Chen Kuo; I-Hui Lee; Tzu-Wen Huang
Journal:  Microorganisms       Date:  2021-06-14

Review 10.  Colistin and its role in the Era of antibiotic resistance: an extended review (2000-2019).

Authors:  Mohamed Abd El-Gawad El-Sayed Ahmed; Lan-Lan Zhong; Cong Shen; Yongqiang Yang; Yohei Doi; Guo-Bao Tian
Journal:  Emerg Microbes Infect       Date:  2020-12       Impact factor: 7.163

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.